The drug, which Lilly in-licensed four years ago and is designed to inhibit a protein known as P2X7, did not meet the company ...

Eli Lilly, Zyrtec and Astellas Pharma recently invested in celeb partnerships to raise awareness about conditions.

Welcome back to Changing Faces, in our final round-up for August and September there are plenty of Board appointments to ...

4D Molecular Therapeutics has sold the Asia-Pacific rights to its eye gene therapy to Otsuka Pharmaceutical, securing $85 ...

The US Health Resources and Services Administration (HRSA) has approved nine drugs for a pilot testing a new rebate model ...

Pharmaceutical titan Eli Lilly has delivered a quarterly report that dramatically surpassed market forecasts, sending waves ...

Major stock indexes declined Thursday as investors digested several big tech earnings reports and awaited more after the ...

Alnylam Pharmaceuticals, Inc. is rated Hold due to high expectations, competitive threats, and revenue expansion. Learn more ...

GPU semiconductor factory, Jensen Huang’s roadmap connects data centers, networks, and industrial systems into a ...

After the Nasdaq sets a seven-year record, a slew of high flying stocks report in the coming week. Plus there's a bonus day from Tesla.

Q3 2025 Earnings Call Transcript October 29, 2025 NiSource Inc. misses on earnings expectations. Reported EPS is $0.19 EPS, ...

Story continues below this ad After her first few injections of Mounjaro ... While India’s top drug regulator, the Central ...